A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

825

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

December 22, 2027

Study Completion Date

December 22, 2027

Conditions

Carcinoma, Non-Small-Cell Lung

Trial Locations (1)

Local Institution - 0001, Leipzig